Skip to content

Ayahuasca research published in 2026

Page 2 of 5: studies 21 to 40 of 85, newest first. Back to the ayahuasca overview

Studies

Longitudinal changes in depressive symptoms following naturalistic ayahuasca use: A prospective cohort study in Las Vegas, Nevada

medRxiv August 27, 2026 Krista Whitley, Kai Davide Castellarin, Kumar Dave et al. preprint

Abstract Ayahuasca use has expanded beyond its traditional Amazonian contexts, yet prospective longitudinal data examining depressive symptoms following naturalistic use in the United States remain limited. We conducted an interim analysis of an ongoing prospective observational cohort of adults participating in naturalistic ayahuasca use in Las Vegas, Nevada. Depressive symptoms were assessed...

Exploring Ayahuasca Multitarget Potential in Neuropsychiatric Disorders: Integrated Insights Towards Drug Discovery

Current Pharmacology Reports August 24, 2026 John I. Ogbu, Caroline V. L. Moreira, Ayobami J. Olusola et al.

Abstract Purpose of Review This review integrates evidence from the literature with network pharmacology tools to explore the decoction’s multitarget potential and provide multilevel insights into its therapeutic role in neuropsychiatric disorders. Recent Findings Neuropsychiatric disorders remain a significant health burden, underscoring the limitations of single-target pharmacotherapies and...

Arte Visionario con San Pedro y Ayahuasca en Ecuador, en diálogo con el mundo Kichwa

Proa Revista de Antropologia e Arte August 19, 2026 Susan Elizabeth Rocha

This research addresses visionary practices in contemporary Ecuadorian art, focusing on their relationship with the ritual ingestion of San Pedro (Echinopsis pachanoi) and Ayahuasca (Banisteriopsis caapi). From a perspective grounded in animist ontologies, which understand nature as a vast web of interconnected beings with interiority, the study analyzes how these master plants function as...

A Matrix-Reduced Whole-Plant Approach to Ayahuasca Preparation: Co-Extraction of Banisteriopsis caapi and Psychotria viridis

International Journal For Multidisciplinary Research August 16, 2026 Eric P. Rubenstein

Ayahuasca is traditionally prepared by aqueous extraction and concentration of Banisteriopsis caapi and Psychotria viridis. The resulting beverage contains N,N-dimethyltryptamine (DMT), harmine, harmaline, tetrahydroharmine (THH), additional alkaloids, polyphenolic constituents, carbohydrates, organic acids, suspended solids, and numerous other plant-derived compounds. The source plants are...

Ayahuasca rituals among ultra-Orthodox (Haredi) Jews: context, phenomenology, changes, and negotiations

PsyArXiv Preprints August 14, 2026 preprint

Background: Despite the rapid growth of psychedelic research, limited attention has been given to how psychedelics are used, experienced and integrated within highly conservative religious communities, and in Jewish contexts more broadly. This study addresses this gap by examining ayahuasca use among the ultra-Orthodox (Haredi) community, a highly religious, conservative, and collectivist...

DOI: osf:sf3uq_v4 (opens in new tab) Full text (opens in new tab) Religion and spirituality Clinical psychology Psychopharmacology Cultural psychology

The Australian Ayahuasca Dietero Networks: Culture, Community, and Practices

Contemporary Drug Problems August 11, 2026 Alana Roy, M.l. Williams, Kimberley Day et al.

Alternative healthcare practices using psychedelic “plant medicines,” such as ayahuasca, challenge current prohibition and mainstream healthcare frameworks. Despite the criminalization of ayahuasca's active component, N,N-dimethyltryptamine (DMT), Australian ayahuasca dietero networks have developed sophisticated healthcare systems with systematic assessment processes, safety mechanisms, and...

Relationship Between Ayahuasca Use and Cotard Syndrome: Is the Subjective Experience of Death a Potential Capacity of the Human Psyche?

Zenodo (CERN European Organization for Nuclear Research) August 7, 2026 Elena María Martínez Gijón preprint

The aim of the present work is to explore possible similarities between the subjective experience of “being dead” described by some individuals following ayahuasca use and the conviction of being dead that may occur in certain cases of Cotard syndrome. Interest in this question arises from a recurring observation, both in testimonies collected directly and in accounts publicly available on the...

Beyond Enthusiasm: Ayahuasca and the Future of Depression Research.

Revista Brasileira de Psiquiatria July 7, 2026 Alberto Souza Sá Filho, James Oluwagbamigbe Fajemiroye, Antonio Egidio Nardi et al.

Few topics in contemporary psychiatry generate as much fascination, hope, and discomfort as the therapeutic use of psychedelics.For some, they represent a long-awaited disruption in the treatment of depression, a field in which many patients still experience partial response, relapse, or treatment resistance despite decades of

Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review

Mexican Journal of Medical Research ICSA July 5, 2026 Omar Azuara-Antonio, Erika Rubí de la Cruz-Elizaldeb, José Eduardo Carmona-Rodriguez et al.

The Psilocybe cubensis mushroom is recognized as the primary source of psilocybin in the Americas, occurring naturally across various regions. This fungus has a long history of use in Mesoamerican rituals due to its capacity to induce altered states of consciousness. The defining characteristic of Psilocybe mushrooms is their psilocybin content. Following ingestion, psilocybin is metabolized...

Effects of an international ceremonial ayahuasca retreat on the diversity and community composition of the human gut microbiome: A preliminary observational single-arm pre-post study

Brain Behavior and Immunity Integrative July 1, 2026 Lyanna R. Kessler, Lamya'a Dawud, John D. Sterrett et al.

ABSTRACT Posttraumatic stress disorder (PTSD) is a mental health condition that can develop following exposure to a traumatic event, often with persistent anxiety and depressive symptoms. Recent research suggests the microbiome-gut-brain axis may play an important role in the etiology and pathophysiology of PTSD. At the same time, retreats incorporating psychedelic-assisted therapies have...

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review.

Clinical Pharmacology & Therapeutics July 1, 2026 Tijana Stojanovic, Kent W Nilsson, Robert Fredriksson et al.

Interest in ayahuasca and its main component, N,N-Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited. We therefore systematically examined registered interventional trials of DMT, ayahuasca, and DMT combined with...

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 1, 2026 Guilherme Lodetti, Rafael Mariano de Bitencourt, Antonio Inserra et al.

BackgroundAlcohol use disorder (AUD) remains difficult to treat with lasting success, leading to growing interest in alternative therapeutic approaches. Psychedelic compounds such as Ayahuasca, a traditional brew used in Indigenous Amazonian ceremonies containing N,N-dimethyltryptamine (DMT) along with monoamine oxidase-inhibiting β-carbolines, have shown promise in reducing addictive...

DOI: 10.1016/j.pnpbp.2026.111817 (opens in new tab) Ayahuasca Serotonin Oxidative stress Glutathione peroxidase +12

Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.

Neuropsychiatrie June 30, 2026 Cielo A Estela-Fernandez, Reem Mohamed Yousif Elsheikh, Dal Bianco Beatrice et al.

Major depressive disorder (MDD) is a heterogeneous, debilitating disorder. A distinct subgroup within the MDD spectrum is identified to have treatment-resistant depression (TRD). There is an impetus to find alternative treatments for TRD to reduce disease burden and improve quality of life. Psychedelics have been used in the treatment of various psychiatric disorders since the 1950s, with...

EXPANSÃO GLOBAL DA AYAHUASCA E SAÚDE MENTAL

Interações - cultura e comunidade June 23, 2026 Leonardo Tondato Mello, Kemily Bakri Ottoni, Janaína Liz Aquino

Este artigo reflete sobre a expansão global da Ayahuasca e suas implicações para a redução de danos em saúde mental e para as transformações na psique individual e coletiva. Tem como objetivo analisar os potenciais psicoterapêuticos e os desafios psicossociais do uso da Ayahuasca por pessoas não indígenas formadas sob pilares antropocêntricos. Para isso, realizou-se uma revisão bibliográfica a...

DOI: 10.5752/p.1983-2478.2026v21n1e211d04 (opens in new tab) Ayahuasca Context archaeology Mental health Perspective graphical +2

Global pressure on ayahuasca threatens Amazonian plants and knowledge systems

June 23, 2026 Carlos Minuano

“One of the world’s largest pharmacies is being destroyed,” says Benki Piyãko, a leader of the Ashaninka Indigenous people in the Brazilian state of Acre. The warning points to multiple threats advancing on the Amazon but also to growing debate surrounding one of the so-called forest medicines: ayahuasca. This Indigenous beverage with psychedelic properties is […]

DOI: 10.66709/news-321692 (opens in new tab) Ayahuasca Amazon rainforest Indigenous Traditional knowledge +8

Koshering Psychedelics: Ayahuasca in the Ultra-Orthodox (Haredi) Jewish World

June 21, 2026 Jonathan David, Aviva Berkovich-Ohana, Yair Dor-Ziderman et al. preprint

Background: Despite the rapid growth of psychedelic research, limited attention has been given to how psychedelics are used, experienced and integrated within highly conservative religious communities, and in Jewish contexts more broadly. This study addresses this gap by examining ayahuasca use among the ultra-Orthodox (Haredi) community, a highly religious, conservative, and collectivist...

Beliefs in and experiences of sorcery, black magic and brujería among psychedelic users: a quantitative and qualitative survey

June 19, 2026 Jules Evans, Christian Jurlando, David Luke et al. preprint

Sorcery, black magic, and supernatural harm are central to many Amazonian shamanic traditions, yet their role in contemporary Western psychedelic culture has received little systematic empirical attention. Ethnographic work suggests that Western participants in ayahuasca tourism often downplay indigenous sorcery frameworks in favour of psychological or therapeutic interpretations of difficult...

Brain-body integromics of the ayahuasca experience.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie June 1, 2026 Francisco Madrid-Gambin, Pablo Mallaroni, Noemí Haro et al.

Ayahuasca is a psychoactive brew containing N,N-dimethyltryptamine (DMT) and β-carboline alkaloids that induces marked alterations in perception, emotion and self-referential processing. However, the multiscale biological organization linking peripheral metabolism, brain network dynamics, neurochemistry, and subjective experience in humans remains poorly understood. Here, we applied an...

An exploratory persistent-homology analysis of resting-state fMRI functional connectivity under Ayahuasca

Chaos Solitons & Fractals May 30, 2026 Tales Ramos Monteiro Dos Santos, Draulio B Araujo, Helcio Felippe et al.

Psychedelic states offer a useful setting for studying changes in large-scale brain organization. Here, we applied Topological Data Analysis (TDA) to resting-state fMRI functional connectivity from nine participants scanned before and after Ayahuasca ingestion. Vietoris–Rips filtrations were constructed from correlation-derived dissimilarity matrices, and persistent entropy was used to quantify...

DOI: 10.1016/j.chaos.2026.118554 (opens in new tab) Ayahuasca Functional connectivity Exploratory analysis Resting State FMRI +3

Phytochemical and Neuropharmacological Evaluation of Banisteriopsis caapi, Paullinia cupana, and Turnera diffusa for Potential Anti-Addiction Activity

Journal of Advances in Medicine and Pharmaceutical Sciences May 24, 2026 Fernando Benevenuto, Iscia Martha Franco, Antonio Eizirik et al.

Addiction remains a major neuropsychiatric challenge, with dopaminergic, serotonergic, and GABAergic dysregulation underlying maladaptive behaviors. Traditional Brazilian medicinal plants offer a rich source of neuroactive compounds, yet their multi-target mechanisms remain underexplored. This study aimed to evaluate the neuropharmacological potential of harmine, caffeine, and damianin through...

DOI: 10.36079/lamintang.jamaps-0501.935 (opens in new tab) Phytochemical Allosteric modulator In silico Docking animal +6